NCT01730378 Immunogenicity and Safety of PrepandrixTM in Korean Subjects Aged 18 to 60 Years Old Status COMPLETED Phase PHASE4
NCT01728753 T-705a Multicenter Study in Adults Subjects With Uncomplicated Influenza Status COMPLETED Phase PHASE1/PHASE2
NCT01728090 Effectiveness of a Handwashing Programme in the Prevention of School Absenteeism Due to Respiratory Infections Status COMPLETED Phase PHASE4
NCT01719874 Influenza Virus Challenge Study to Test Monoclonal Antibody TCN-032 as a Treatment for Influenza Status UNKNOWN Phase PHASE2
NCT01719783 Reactogenicity, Safety, and Immunogenicity of a Live Monovalent H5N2 Influenza Vaccine Status COMPLETED Phase PHASE1
NCT01715909 A Pharmacokinetic/Pharmacodynamic Study of Oseltamivir in Immunocompromised Children With Confirmed Influenza Infection Status COMPLETED Phase PHASE1
NCT01715792 Assess the Risk of Solid Organ Transplant Rejection Following Vaccination With Pandemrix™ in UK Status COMPLETED Phase N/A
NCT01712984 Study of Intradermal Quadrivalent Influenza Vaccine in Adults Aged 18 Through 64 Years Status COMPLETED Phase PHASE3
NCT01711736 Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine GSK2282512A When Administered to Children 6 to 35 Months of Age Status COMPLETED Phase PHASE3
NCT01702454 Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345 Status COMPLETED Phase PHASE3
NCT01698177 Optimizing Influenza Vaccination in Surgical Oncology Patients Status UNKNOWN Phase PHASE4
NCT01693380 Effectiveness Assessment of Vaccinating Schoolchildren Against Influenza Status COMPLETED Phase PHASE4
NCT01691339 Study of Fluzone® Influenza Virus Vaccines 2012-2013 Formulation Among Adults. Status COMPLETED Phase PHASE4
NCT01691326 Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Influenza Virus Vaccine (2012-2013 Formulation) Status COMPLETED Phase PHASE4
NCT01688297 Safety Study of an Oral Vaccine to Prevent Seasonal Influenza Status COMPLETED Phase PHASE1
NCT01683630 Comparison of Epidemiology and Clinical Outcomes of Influenza A & B Cases in Manitoba, Canada Status COMPLETED Phase N/A